Patents by Inventor Zongming Fu

Zongming Fu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200292558
    Abstract: Described herein are methods for identification/discovery of protein biomarkers for chronic kidney disease (CKD) and diagnosing and/or prognosing and/or predicting progression of and/or treating chronic kidney disease (CKD).
    Type: Application
    Filed: October 12, 2018
    Publication date: September 17, 2020
    Applicants: Cedars-Sinai Medical Center, THE JOHNS HOPKINS UNIVERSITY
    Inventors: Jennifer VAN EYK, Qin FU, Vidya VENKATRAMAN, Zongming FU, Josef CORESH
  • Patent number: 10215764
    Abstract: The present invention relates to the field of biomarkers. More specifically, the present invention relates to assay reagents useful in detecting neurogranin. In a specific embodiment, the present invention provides an isolated antibody or fragment thereof that specifically binds to neurogranin. In another embodiment, the present invention provides a polynucleotide aptamer that specifically binds neurogranin.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: February 26, 2019
    Assignee: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Allen Dale Everett, Jun Yang, Zongming Fu
  • Publication number: 20170315138
    Abstract: The present invention relates to the field of biomarkers. More specifically, the present invention relates to assay reagents useful in detecting neurogranin. In a specific embodiment, the present invention provides an isolated antibody or fragment thereof that specifically binds to neurogranin. In another embodiment, the present invention provides a polynucleotide aptamer that specifically binds neurogranin.
    Type: Application
    Filed: June 30, 2017
    Publication date: November 2, 2017
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: ALLEN DALE EVERETT, JUN YANG, ZONGMING FU
  • Patent number: 9709578
    Abstract: The present invention relates to the field of biomarkers. More specifically, the present invention relates to assay reagents useful in detecting neurogranin. In a specific embodiment, the present invention provides an isolated antibody or fragment thereof that specifically binds to neurogranin. In another embodiment, the present invention provides a polynucleotide aptamer that specifically binds neurogranin.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: July 18, 2017
    Assignee: The Johns Hopkins University
    Inventors: Allen Dale Everett, Jun Yang, Zongming Fu
  • Publication number: 20170038397
    Abstract: The present invention relates to the field of biomarkers. More specifically, the present invention relates to assay reagents useful in detecting neurogranin. In a specific embodiment, the present invention provides an isolated antibody or fragment thereof that specifically binds to neurogranin. In another embodiment, the present invention provides a polynucleotide aptamer that specifically binds neurogranin.
    Type: Application
    Filed: September 29, 2016
    Publication date: February 9, 2017
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: ALLEN DALE EVERETT, JUN YANG, ZONGMING FU
  • Publication number: 20150072360
    Abstract: Methods are disclosed for predicting or diagnosing pulmonary artery hypertension (PAH) and for determining the efficacy of PAH therapy using biomarkers.
    Type: Application
    Filed: December 14, 2012
    Publication date: March 12, 2015
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Allen Dale Everett, Zongming Fu
  • Publication number: 20140141458
    Abstract: The present invention relates to the field of biomarkers. More specifically, the present invention relates to assay reagents useful in detecting neurogranin. In a specific embodiment, the present invention provides an isolated antibody or fragment thereof that specifically binds to neurogranin. In another embodiment, the present invention provides a polynucleotide aptamer that specifically binds neurogranin.
    Type: Application
    Filed: May 14, 2012
    Publication date: May 22, 2014
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Allen Dale Everett, Jun Yang, Zongming Fu
  • Publication number: 20120004133
    Abstract: Methods for determining if a subject has or is susceptible to having an age-associated vascular disorder are disclosed. The method includes determining if the subject exhibits altered expression of a product of one or more of the genes listed in Table 1 relative to a control level of expression of the gene product. Altered expression of one or more of the genes listed in Table 1 indicates that the subject has or is susceptible to having an age-associated vascular disorder. In specific examples the gene product is a product of the MFG-E8 and an increase in expression indicates the subject has or is susceptible to having an age-associated vascular disorder.
    Type: Application
    Filed: February 19, 2010
    Publication date: January 5, 2012
    Inventors: Mingyi Wang, Zongming Fu, Edward G. Lakatta, Jennifer Van Eyk